查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044478

寵物預防保健市場預測至2034年－全球產品、服務、動物種類、預防保健重點領域、交付方式、最終用戶、通路和區域分析

Pet Preventive Healthcare Market Forecasts to 2034 - Global Analysis By Product, Service, Animal Type, Preventive Care Focus, Delivery Mode, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球寵物預防保健市場規模將達到 113 億美元，並在預測期內以 9.3% 的複合年成長率成長，到 2034 年將達到 231 億美元。

寵物預防保健是指所有旨在維護動物健康、預防疾病發生以及在潛在疾病發展成嚴重疾病之前發現它們的預防性醫療措施。這包括常規疫苗接種、寄生蟲防治、營養補充、定期體檢、牙齒護理和診斷篩檢。隨著寵物飼主越來越將他們心愛的動物視為家庭成員，預防保健方面的支出顯著增加，獸醫醫療產業也正從被動治療轉向全面的健康管理計劃，以延長犬、貓和其他伴侶動物的壽命並提高它們的生活品質。

寵物日益「擬人化」以及動物福利支出不斷增加

在已開發經濟體和新興經濟體中，寵物飼主越來越將寵物視為家庭成員，因此更願意投資預防性醫療保健服務。這種情感連結促使他們定期帶寵物去看獸醫、按時接種疫苗，並主動購買驅蟲藥和營養補充劑。研究表明，寵物「擬人化」與寵物健康計劃、牙科護理和定期體檢方面的支出增加直接相關。隨著千禧世代和Z世代推遲生育子女，許多人選擇養寵物，推動了寵物照護的優質化。這種文化轉變已將預防性醫療保健從一項可有可無的支出轉變為各個收入階層負責任的寵物飼養的必備要素。

綜合預防性醫療保健方案成本高昂

年度健康檢查、強制疫苗接種、寄生蟲預防、洗牙和診斷篩檢的累積費用對許多寵物飼主來說是一筆不小的開銷。與可以延後的對症治療不同，預防性護理需要持續的自付費用，而且往往無法立即見效。在寵物保險不普及的地區，寵物主人可能會選擇法律規定的最低服務項目，而不是全面的照護方案。景氣衰退會進一步加劇家庭預算壓力，導致寵物主人延遲體檢，甚至放棄預防性藥物。這種對費用的敏感度限制了市場擴張，尤其是在低收入家庭和獸醫服務補貼很少或沒有補貼的國家。

拓展寵物健康計畫與訂閱模式

獸醫診所和連鎖店正擴大推出健康計劃，將常規預防保健服務打包成價格實惠的月費套餐。這些模式透過分攤費用鼓勵飼主持續使用，為獸醫診所提供穩定的收入，並自動發送定期預約提醒。訂閱計劃通常包括疫苗接種、健康檢查、寄生蟲預防以及附加服務的折扣，使全面的寵物護理更加便利。隨著遠端醫療和行動獸醫服務的普及，訂閱模式也擴展到線上諮詢、營養諮詢和預防產品宅配服務等領域。這種持續的收入模式既穩定了市場，也降低了對價格敏感的寵物飼主接受持續預防保健的門檻。

寵物飼主對疫苗接種的猶豫與誤解

社群媒體和個人軼事傳播的錯誤訊息導致一些寵物飼主質疑常規疫苗接種的安全性和必要性，這一趨勢與人類醫學領域的情況類似。疫苗相關的不利事件、過度接種以及對自然免疫的擔憂，都加劇了人們對必要和非必要疫苗的抗拒。這種猶豫不決威脅著群體免疫，並增加了犬細小病毒和犬瘟熱等可預防疾病爆發的風險。獸醫專業人員必須花費大量時間來教育那些不願意接種疫苗的飼主，一些獸醫診所也報告說疫苗接種率正在下降。如果這種趨勢加劇，可能會破壞數十年來在防治伴侶動物感染疾病的進展。

新冠疫情的感染疾病：

疫情初期，由於封鎖措施導致動物醫院就診受限，獸醫服務一度中斷，但寵物預防保健的需求迅速恢復，並超過了疫情前的水平。隔離期間，新寵物領養數量激增，需要首次接種疫苗和進行健康檢查的動物數量也隨之增加。遠距醫療諮詢服務迅速發展，使得人們能夠遠距獲得營養指導和行為建議，同時確保預防保健服務的連續性。在家工作的飼主更重視寵物的健康，即使是細微的變化也會及時發現並帶它們去看獸醫。這種健康意識的提高，加上人們因旅行和外食而增加的可支配收入，共同推動了疫情後預防保健產品和服務的持續成長。

在預測期內，疫苗產業預計將佔據最大的市場佔有率。

預計在預測期內，疫苗產業將佔據最大的市場佔有率，因為它在預防高傳染性和致命性感染疾病發揮著至關重要的作用。許多地區強制要求接種狂犬病、犬瘟熱、犬細小病毒和犬腺病毒的基礎疫苗，確保了疫苗需求的穩定，不受經濟狀況的影響。年度或三年一次的加強免疫接種計劃為疫苗生產商和獸醫診所提供了持續的收入來源。完善的分銷基礎設施，包括冷藏供應鏈和完善的接種流程，確保了疫苗在已開發市場的廣泛供應。同樣，新興市場也將狂犬病根除計畫列為優先事項，這進一步鞏固了疫苗在整個預測期內作為寵物預防保健基石的地位。

在預測期內，營養諮詢產業預計將呈現最高的複合年成長率。

在預測期內，營養諮詢領域預計將呈現最高的成長率。這反映出人們越來越意識到飲食直接影響寵物慢性疾病的預防。飼主正在尋求專家指導，以控制體重、預防食物過敏、制定腎臟保健飲食方案以及根據寵物年齡調整營養，從而避免肥胖相關疾病，例如糖尿病和關節炎。獸醫診所正在將營養諮詢納入健康套餐，聘請認證營養師，並利用遠端醫療平台提供後續支援。處方糧、功能性點心和客製化飲食計畫的普及，業務收益。隨著全球寵物肥胖率的上升，對實證營養建議的需求成長速度將超過任何其他預防性服務類別。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其最高的寵物擁有率、先進的獸醫基礎設施和較高的寵物保險普及率。僅美國就佔全球預防性醫療保健支出的很大一部分，這主要得益於其較高的可支配收入和重視動物健康的文化習俗。成熟的獸醫診所提供全面的健康計劃，而醫藥創新也主要由北美公司推動。診斷篩檢、牙齒預防保健和營養補充劑的廣泛應用反映了消費者日益成熟的健康意識。確保疫苗安全性和驅蟲藥有效性的法律規範將在整個預測期內進一步鞏固該地區在所有產品和服務類別中的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要得益於中國、印度和東南亞國家寵物擁有的快速成長，以及隨之而來的中產階級可支配所得的提高。都市化和出生率下降推動了寵物「人性化」趨勢，與西方市場的趨勢類似，飼主也越來越願意在獸醫保健服務上投入資金。先前發展滯後的獸醫基礎設施，隨著國際連鎖醫院的進入和本地診所的現代化而擴大。政府為防治狂犬病和通用感染疾病所做的努力，提高了人們對疫苗接種的認知。隨著西方寵物護理品牌進入這些市場，以及本地新創公司提供價格合理的訂閱式健康計劃，亞太地區正在成為寵物預防保健普及率成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球寵物預防保健市場：依產品分類

  • 疫苗
  • 殺蟲劑
  • 營養補充品
  • 預防性藥物
  • 診斷與篩檢試劑盒

第6章：全球寵物預防保健市場：依服務分類

  • 定期健康檢查
  • 疫苗接種服務
  • 牙科護理
  • 營養諮詢
  • 儀容及衛生服務

第7章：全球寵物預防保健市場：依動物類型分類

  • 狗
  • 貓
  • 其他伴侶動物

第8章：全球寵物預防保健市場：依預防保健領域分類

  • 感染疾病預防
  • 寄生蟲預防
  • 預防慢性疾病
  • 口腔和牙齒健康
  • 皮膚和毛髮健康
  • 消化器官系統健康

第9章：全球寵物預防保健市場：以交付方式分類

  • 院內服務
  • 居家照護
  • 遠端醫療服務

第10章：全球寵物預防保健市場：以最終用戶分類

  • 寵物飼主
  • 獸醫醫院和診所
  • 寵物護理中心

第11章：全球寵物預防保健市場：依分銷管道分類

  • 動物醫院
  • 零售藥房
  • 線上平台

第12章 全球寵物預防保健市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第13章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第14章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第15章：公司簡介

  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • Heska Corporation
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • PetIQ Inc.
  • Trupanion Inc.
  • Nationwide Mutual Insurance Company
  • Fressnapf Holding SE
Product Code: SMRC36267

According to Stratistics MRC, the Global Pet Preventive Healthcare Market is accounted for $11.3 billion in 2026 and is expected to reach $23.1 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Pet preventive healthcare encompasses all proactive medical measures designed to maintain animal health, prevent disease onset, and detect potential conditions before they become serious. This includes routine vaccinations, parasite control, nutritional supplements, regular check-ups, dental care, and diagnostic screenings. As pet owners increasingly view their animals as family members, spending on preventive care has risen substantially, shifting the veterinary industry from reactive treatment toward comprehensive wellness programs that extend pet longevity and improve quality of life across dogs, cats, and other companion animals.

Market Dynamics:

Driver:

Rising pet humanization and increased spending on animal wellness

Pet owners across developed and emerging economies are treating their animals as family members, leading to greater willingness to invest in preventive healthcare services. This emotional bond translates into regular veterinary visits, adherence to vaccination schedules, and proactive purchase of parasiticides and nutritional supplements. Studies indicate that pet humanization correlates directly with higher expenditure on wellness plans, dental procedures, and routine diagnostics. As millennials and Gen Z delay having children, many substitute with pets, driving premiumization of pet care. This cultural shift has transformed preventive healthcare from an optional expense into a standard component of responsible pet ownership across all income segments.

Restraint:

High cost of comprehensive preventive care packages

The cumulative expense of annual wellness visits, core vaccines, parasite prevention, dental cleanings, and diagnostic screenings presents a significant financial barrier for many pet owners. Unlike reactive treatment that may be deferred, preventive care requires consistent out-of-pocket spending, often without immediate visible benefits. In regions without pet insurance penetration, owners may opt for minimal legally required services rather than comprehensive protocols. Economic downturns further pressure household budgets, leading to delayed check-ups or skipped doses of preventive medications. This cost sensitivity limits market expansion, particularly among lower-income households and in countries where veterinary services remain largely unsubsidized.

Opportunity:

Expansion of pet wellness plans and subscription-based models

Veterinary practices and corporate chains are increasingly offering bundled wellness plans that package routine preventive services into affordable monthly subscriptions. These models improve owner compliance by spreading costs, ensuring regular cash flow for clinics, and automatically scheduling reminder visits. Subscription plans typically include vaccinations, check-ups, parasite prevention, and discounts on additional services, making comprehensive care more accessible. As telemedicine and mobile veterinary services grow, subscription models extend to virtual consultations, nutritional counseling, and home-delivered preventive products. This recurring revenue approach stabilizes the market while lowering barriers to consistent preventive care adoption among price-sensitive pet owners.

Threat:

Vaccine hesitancy and misinformation among pet owners

Misinformation spread through social media and anecdotal reports has led some pet owners to question the safety and necessity of routine vaccinations, paralleling trends seen in human healthcare. Concerns about vaccine-associated adverse events, over-vaccination, and natural immunity have fueled resistance to core and non-core vaccines. This hesitancy threatens population-level herd immunity, increasing outbreak risks for preventable diseases such as parvovirus and distemper. Veterinary professionals must spend considerable time educating reluctant owners, and some clinics report declining vaccination compliance rates. If this trend intensifies, it could undermine decades of progress in infectious disease control among companion animals.

Covid-19 Impact:

The pandemic initially disrupted veterinary services as lockdowns limited access to clinics, but demand for pet preventive care rebounded strongly and exceeded pre-pandemic levels. Adoption of new pets surged during isolation periods, creating a larger base of animals requiring initial vaccination series and wellness exams. Telemedicine consultations expanded rapidly, enabling remote nutritional counseling and behavior advice while maintaining preventive care continuity. Pet owners working from home became more attentive to animal health, noticing subtle changes that prompted veterinary visits. This heightened awareness, combined with increased disposable income redirected from travel and dining, resulted in durable growth for preventive healthcare products and services post-pandemic.

The Vaccines segment is expected to be the largest during the forecast period

The Vaccines segment is expected to account for the largest market share during the forecast period, driven by their fundamental role in preventing highly contagious and potentially fatal infectious diseases. Core vaccines against rabies, distemper, parvovirus, and adenovirus are legally mandated in many jurisdictions, ensuring consistent demand regardless of economic conditions. Annual or triennial booster schedules create recurring revenue streams for manufacturers and veterinary practices. The established distribution infrastructure, including refrigerated supply chains and administration protocols, has made vaccines universally accessible across developed markets. Emerging markets are similarly prioritizing rabies eradication programs, further cementing vaccines as the cornerstone of pet preventive healthcare throughout the forecast timeline.

The Nutritional Counseling segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Nutritional Counseling segment is predicted to witness the highest growth rate, reflecting increasing recognition that diet directly impacts chronic disease prevention in pets. Owners are seeking professional guidance on weight management, food allergies, renal support diets, and age-appropriate nutrition to avoid obesity-related conditions like diabetes and arthritis. Veterinary practices are integrating nutritional consultations into wellness packages, employing certified nutritionists and leveraging telehealth platforms for follow-up support. The proliferation of prescription diets, functional treats, and customized meal plans has created new service revenue streams. As pet obesity rates rise globally, demand for evidence-based nutritional advice will accelerate faster than any other preventive service category.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by the highest pet ownership rates, advanced veterinary infrastructure, and strong pet insurance penetration. The United States alone accounts for a substantial portion of global preventive healthcare spending, driven by high disposable incomes and cultural norms that prioritize animal wellness. Established veterinary practices offer comprehensive wellness plans, and pharmaceutical innovation originates predominantly from North American companies. Widespread adoption of diagnostic screening, dental prophylaxis, and nutritional supplements reflects mature consumer awareness. Regulatory frameworks ensuring vaccine safety and parasiticides efficacy further reinforce the region's dominance across all product and service categories throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly rising pet ownership in China, India, and Southeast Asian nations, accompanied by growing middle-class disposable income. Urbanization and smaller family sizes are driving pet humanization trends similar to Western markets, with owners increasingly willing to spend on veterinary wellness services. Previously underdeveloped veterinary infrastructure is expanding with international hospital chains and local clinic modernization. Government initiatives for rabies control and zoonotic disease prevention promote vaccination awareness. As Western pet care brands enter these markets and local startups offer affordable subscription wellness plans, Asia Pacific emerges as the fastest-growing region for pet preventive healthcare adoption.

Key players in the market

Some of the key players in Pet Preventive Healthcare Market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Virbac, Ceva Sante Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Heska Corporation, IDEXX Laboratories Inc., Neogen Corporation, PetIQ Inc., Trupanion Inc., Nationwide Mutual Insurance Company, and Fressnapf Holding SE.

Key Developments:

In March 2026, FDA approved BRAVECTO(R) QUANTUM, a 12-month injectable suspension for dogs to treat and control Asian Longhorned and Gulf Coast ticks, representing a major advancement in long-term preventive parasite control.

In December 2025, Zoetis received regulatory approval in the European Union and Canada for Portela, the first monoclonal antibody therapy with a three-month dosing interval for cats, addressing a significant unmet need in long-term preventive pain management.

In October 2025, Boehringer Ingelheim entered a strategic collaboration with Eko Health Inc. to integrate AI-powered digital stethoscopes into veterinary clinics, enabling earlier detection of heart and lung diseases in dogs.

Products Covered:

  • Vaccines
  • Parasiticides
  • Nutritional Supplements
  • Preventive Pharmaceuticals
  • Diagnostics & Screening Kits

Services Covered:

  • Routine Health Check-ups
  • Vaccination Services
  • Dental Care
  • Nutritional Counseling
  • Grooming & Hygiene Services

Animal Types Covered:

  • Dogs
  • Cats
  • Other Companion Animals

Preventive Care Focus Covered:

  • Infectious Disease Prevention
  • Parasitic Prevention
  • Chronic Disease Prevention
  • Oral & Dental Health
  • Skin & Coat Health
  • Digestive Health

Delivery Modes Covered:

  • In-clinic Services
  • At-home Care
  • Telehealth Services

End Users Covered:

  • Pet Owners
  • Veterinary Clinics & Hospitals
  • Pet Care Centers

Distribution Channels Covered:

  • Veterinary Clinics & Hospitals
  • Retail Pharmacies
  • Online Platforms

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Preventive Healthcare Market, By Product

  • 5.1 Vaccines
  • 5.2 Parasiticides
  • 5.3 Nutritional Supplements
  • 5.4 Preventive Pharmaceuticals
  • 5.5 Diagnostics & Screening Kits

6 Global Pet Preventive Healthcare Market, By Service

  • 6.1 Routine Health Check-ups
  • 6.2 Vaccination Services
  • 6.3 Dental Care
  • 6.4 Nutritional Counseling
  • 6.5 Grooming & Hygiene Services

7 Global Pet Preventive Healthcare Market, By Animal Type

  • 7.1 Dogs
  • 7.2 Cats
  • 7.3 Other Companion Animals

8 Global Pet Preventive Healthcare Market, By Preventive Care Focus

  • 8.1 Infectious Disease Prevention
  • 8.2 Parasitic Prevention
  • 8.3 Chronic Disease Prevention
  • 8.4 Oral & Dental Health
  • 8.5 Skin & Coat Health
  • 8.6 Digestive Health

9 Global Pet Preventive Healthcare Market, By Delivery Mode

  • 9.1 In-clinic Services
  • 9.2 At-home Care
  • 9.3 Telehealth Services

10 Global Pet Preventive Healthcare Market, By End User

  • 10.1 Pet Owners
  • 10.2 Veterinary Clinics & Hospitals
  • 10.3 Pet Care Centers

11 Global Pet Preventive Healthcare Market, By Distribution Channel

  • 11.1 Veterinary Clinics & Hospitals
  • 11.2 Retail Pharmacies
  • 11.3 Online Platforms

12 Global Pet Preventive Healthcare Market, By Geography

  • 12.1 North America
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Mexico
  • 12.2 Europe
    • 12.2.1 United Kingdom
    • 12.2.2 Germany
    • 12.2.3 France
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Netherlands
    • 12.2.7 Belgium
    • 12.2.8 Sweden
    • 12.2.9 Switzerland
    • 12.2.10 Poland
    • 12.2.11 Rest of Europe
  • 12.3 Asia Pacific
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 South Korea
    • 12.3.5 Australia
    • 12.3.6 Indonesia
    • 12.3.7 Thailand
    • 12.3.8 Malaysia
    • 12.3.9 Singapore
    • 12.3.10 Vietnam
    • 12.3.11 Rest of Asia Pacific
  • 12.4 South America
    • 12.4.1 Brazil
    • 12.4.2 Argentina
    • 12.4.3 Colombia
    • 12.4.4 Chile
    • 12.4.5 Peru
    • 12.4.6 Rest of South America
  • 12.5 Rest of the World (RoW)
    • 12.5.1 Middle East
      • 12.5.1.1 Saudi Arabia
      • 12.5.1.2 United Arab Emirates
      • 12.5.1.3 Qatar
      • 12.5.1.4 Israel
      • 12.5.1.5 Rest of Middle East
    • 12.5.2 Africa
      • 12.5.2.1 South Africa
      • 12.5.2.2 Egypt
      • 12.5.2.3 Morocco
      • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

  • 13.1 Industry Value Network and Supply Chain Assessment
  • 13.2 White-Space and Opportunity Mapping
  • 13.3 Product Evolution and Market Life Cycle Analysis
  • 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

  • 14.1 Mergers and Acquisitions
  • 14.2 Partnerships, Alliances, and Joint Ventures
  • 14.3 New Product Launches and Certifications
  • 14.4 Capacity Expansion and Investments
  • 14.5 Other Strategic Initiatives

15 Company Profiles

  • 15.1 Zoetis Inc.
  • 15.2 Elanco Animal Health Incorporated
  • 15.3 Boehringer Ingelheim International GmbH
  • 15.4 Merck & Co., Inc.
  • 15.5 Virbac
  • 15.6 Ceva Sante Animale
  • 15.7 Vetoquinol S.A.
  • 15.8 Dechra Pharmaceuticals PLC
  • 15.9 Heska Corporation
  • 15.10 IDEXX Laboratories Inc.
  • 15.11 Neogen Corporation
  • 15.12 PetIQ Inc.
  • 15.13 Trupanion Inc.
  • 15.14 Nationwide Mutual Insurance Company
  • 15.15 Fressnapf Holding SE

List of Tables

  • Table 1 Global Pet Preventive Healthcare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Preventive Healthcare Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Pet Preventive Healthcare Market Outlook, By Vaccines (2023-2034) ($MN)
  • Table 4 Global Pet Preventive Healthcare Market Outlook, By Parasiticides (2023-2034) ($MN)
  • Table 5 Global Pet Preventive Healthcare Market Outlook, By Nutritional Supplements (2023-2034) ($MN)
  • Table 6 Global Pet Preventive Healthcare Market Outlook, By Preventive Pharmaceuticals (2023-2034) ($MN)
  • Table 7 Global Pet Preventive Healthcare Market Outlook, By Diagnostics & Screening Kits (2023-2034) ($MN)
  • Table 8 Global Pet Preventive Healthcare Market Outlook, By Service (2023-2034) ($MN)
  • Table 9 Global Pet Preventive Healthcare Market Outlook, By Routine Health Check-ups (2023-2034) ($MN)
  • Table 10 Global Pet Preventive Healthcare Market Outlook, By Vaccination Services (2023-2034) ($MN)
  • Table 11 Global Pet Preventive Healthcare Market Outlook, By Dental Care (2023-2034) ($MN)
  • Table 12 Global Pet Preventive Healthcare Market Outlook, By Nutritional Counseling (2023-2034) ($MN)
  • Table 13 Global Pet Preventive Healthcare Market Outlook, By Grooming & Hygiene Services (2023-2034) ($MN)
  • Table 14 Global Pet Preventive Healthcare Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 15 Global Pet Preventive Healthcare Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 16 Global Pet Preventive Healthcare Market Outlook, By Cats (2023-2034) ($MN)
  • Table 17 Global Pet Preventive Healthcare Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • Table 18 Global Pet Preventive Healthcare Market Outlook, By Preventive Care Focus (2023-2034) ($MN)
  • Table 19 Global Pet Preventive Healthcare Market Outlook, By Infectious Disease Prevention (2023-2034) ($MN)
  • Table 20 Global Pet Preventive Healthcare Market Outlook, By Parasitic Prevention (2023-2034) ($MN)
  • Table 21 Global Pet Preventive Healthcare Market Outlook, By Chronic Disease Prevention (2023-2034) ($MN)
  • Table 22 Global Pet Preventive Healthcare Market Outlook, By Oral & Dental Health (2023-2034) ($MN)
  • Table 23 Global Pet Preventive Healthcare Market Outlook, By Skin & Coat Health (2023-2034) ($MN)
  • Table 24 Global Pet Preventive Healthcare Market Outlook, By Digestive Health (2023-2034) ($MN)
  • Table 25 Global Pet Preventive Healthcare Market Outlook, By Delivery Mode (2023-2034) ($MN)
  • Table 26 Global Pet Preventive Healthcare Market Outlook, By In-clinic Services (2023-2034) ($MN)
  • Table 27 Global Pet Preventive Healthcare Market Outlook, By At-home Care (2023-2034) ($MN)
  • Table 28 Global Pet Preventive Healthcare Market Outlook, By Telehealth Services (2023-2034) ($MN)
  • Table 29 Global Pet Preventive Healthcare Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Pet Preventive Healthcare Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 31 Global Pet Preventive Healthcare Market Outlook, By Veterinary Clinics & Hospitals (2023-2034) ($MN)
  • Table 32 Global Pet Preventive Healthcare Market Outlook, By Pet Care Centers (2023-2034) ($MN)
  • Table 33 Global Pet Preventive Healthcare Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 34 Global Pet Preventive Healthcare Market Outlook, By Veterinary Clinics & Hospitals (2023-2034) ($MN)
  • Table 35 Global Pet Preventive Healthcare Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 36 Global Pet Preventive Healthcare Market Outlook, By Online Platforms (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.